Melatonin Low-Dose for Prevention of Delirium in Critically Ill Patients: A Multi-centre, Randomized, Placebo-controlled Feasibility Trial (MELLOW)

Lisa D. Burry*, David R. Williamson, Michael E. Detsky , Francis Bernard, Jennifer R. Foster, Sangeeta Mehta, Ruxandra Pinto, Damon C. Scales, Louise Rose

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

6 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Melatonin Low-Dose for Prevention of Delirium in Critically Ill Patients: A Multi-centre, Randomized, Placebo-controlled Feasibility Trial (MELLOW)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science